timothy sykes logo
COO Jumps As Cooper Companies Extends Earnings Beat Streak Thumbnail
G Google News

COO Jumps As Cooper Companies Extends Earnings Beat Streak

JACK KELLOGG•UPDATED JUN. 6, 2026, 10:04 AM ET
Reviewed by Ellis Hobbsand Fact-checked by Matt Monaco

The Cooper Companies Inc. surged as stocks have been trading up by 8.47 percent on strong earnings-driven optimism.

Candlestick Chart

Weekly Update Jun 01 – Jun 05, 2026: On Saturday, June 06, 2026 The Cooper Companies Inc. stock [NASDAQ: COO] is trending up by 8.47%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Healthcare industry expert:

Analyst sentiment – positive

Cooper remains a high‑quality ophthalmic and women’s health platform with attractive structural economics but middling returns. Gross margin above 65% and EBITDA margin in the high‑20s confirm strong franchise power, while revenue CAGR near low double digits underscores durable growth. Yet ROIC around 4–5% and ROE sub‑7% lag best‑in‑class med‑tech peers, reflecting heavy intangibles and underutilized assets. Leverage is conservative (D/E ~0.3, interest cover ~12x), liquidity adequate, and FCF conversion solid, supporting buybacks and strategic optionality despite near‑term GAAP losses from litigation.

Technically, COO has pivoted from a mid‑$50s base into a sharp relief rally following earnings. The weekly sequence from ~$59 to above $67 shows a decisive breakout with expanding ranges, consistent with heavy upside volume reported around the post‑print move. Dominant trend is now short‑term bullish within a still‑repairing intermediate downtrend. A specific actionable level is $64–65: this is the first major support zone to buy pullbacks; a sustained break below $60 would negate the bullish setup.

Fundamentally and versus Healthcare and Med‑Tech benchmarks, Cooper screens as a premium‑multiple compounder (P/E ~40, ~3.8x sales) underpinned by high‑visibility recurring revenue, above‑sector margins, and an outlook for >$2.2B FCF in 2026–2028. The fertility media litigation resolution and likely CSI divestiture should refocus the story on CooperVision, improve mix, and lift ROIC toward peer averages. With consensus targets clustered in the mid‑$80s, I see an attractive 12–18‑month risk‑reward, with support near $60 and resistance around $80.

Quick Financial Overview

Cooper Companies Inc. just put up the kind of quarter traders like to see. Q2 2026 revenue came in at $1.08B, beating the $1.05B consensus and rising 8% year over year, with 5% organic growth. Non-GAAP EPS of $1.21 beat the $1.10 estimate and grew 26%, extending a ten-quarter streak of earnings beats. The gap to GAAP EPS of -$0.40 stems from a $271.6M litigation charge tied to the 2023 CooperSurgical fertility media recall, which the company says is largely resolved.

Under the hood, CooperVision and CooperSurgical each posted 8% revenue growth and a combined 27% non-GAAP operating margin. Key ratios support this story: a 65.4% gross margin and 27.2% EBITDA margin highlight strong pricing power in COO’s niches. Revenue has grown at 7.1% over three years and 10.99% over five, while a price-to-sales near 3.84 and price-to-free-cash around 22.9 reflect a quality multiple rather than a deep-value setup.

More Breaking News

On the balance sheet, The Cooper Companies Inc. shows moderate leverage, with total debt-to-equity at 0.3 and interest coverage around 11.7, which traders typically view as manageable. Operating cash flow of about $182.8M and free cash flow near $96.4M for the quarter backstop the >$2.2B multi-year free cash flow target for 2026–2028. On the chart, weekly prices have jumped from roughly $59–$60 into the high $60s after earnings, with an intraday spike from about $65 to nearly $68 on strong five-minute momentum, confirming the news-driven breakout.

Conclusion

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

Click Here for a Millionaire's POV on Trading COO

Millionaire's
POV on COO

Don't miss the next
big breakout.

GET POV
Tim Sykes

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”